LabCorp to price senior notes due 2018 and 2023 in two tranches

By Aleesia Forni

Virginia Beach, Oct. 29 - Laboratory Corp. of America Holdings is planning to bring a two-part sale of notes to market, according to a 424B5 filed with the Securities and Exchange Commission.

The deal is expected to consist of tranches due 2018 and 2023.

The notes will feature a make-whole call.

Barclays, Credit Suisse Securities (USA) LLC, Wells Fargo Securities LLC and Goldman Sachs & Co. are the joint bookrunners.

Proceeds will be used to repay all or a portion of outstanding borrowings under a revolving credit agreement and for general corporate purposes.

The independent clinical laboratory company is based in Burlington, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.